New studies in glioblastoma highlight how PD-1 inhibitors could simultaneously prompt an immune response and steer the selection of tumor clones that evade immune recognition.
from Latest articles from Cancer Therapy Advisor Brain Cancer http://bit.ly/2TQSrMX
from Latest articles from Cancer Therapy Advisor Brain Cancer http://bit.ly/2TQSrMX